The Dylag Lab, led by Andrew M. Dylag, MD, FAAP, investigates the mechanisms by which early-life respiratory exposures, such as oxygen and mechanical ventilation, shape lung development and long-term respiratory outcomes in premature infants. The lab integrates bench, computational, and bedside research to improve lung health and reduce the severity of bronchopulmonary dysplasia (BPD).
Andrew M. Dylag, M.D.
Principal Investigator
- Reducing Opiate and Benzodiazepine Exposure in Preterm Infants on High-Frequency Jet Ventilation.; Pediatrics. 2026 Jan 21.
- Time-Series Machine Learning for Prediction of Bronchopulmonary Dysplasia.; The Journal of pediatrics. 2026 Jan 19.
- Sorted-Cell Proteomics Reveals an AT1-Associated Epithelial Cornification Phenotype and Suggests Endothelial Redox Imbalance in Human Bronchopulmonary Dysplasia.; American journal of physiology. Lung cellular and molecular physiology. 2025 Sep 17.
- The effectiveness of pulmonary hypertension screening in infants born preterm.; Early human development; Vol 209, pp. 106342. 2025 Jul 15.
Contact Us
Dylag Lab
601 Elmwood Avenue
Rochester, NY 14642